Markus Meyer

Markus joined Alentis in Sep 2019. Markus is a senior R&D Leader and Project Management Professional (PMP) with >20 years of drug development experience in multiple aspects of Pharma and Biotech R&D. A molecular biologist by training and drug developer with profound experience from discovery to Phase III with small molecules, antibodies and mRNAs.

Prior to Alentis Markus was Director Project Management at CureVac managing collaboration projects with mRNA-based tumor vaccines in oncology. Previously he was Global Project Leader at Novartis/Sandoz being in charge of global biosimilar projects. Prior that Markus was a Senior R&D Project Leader at Roche responsible for managing global drug development projects in several therapeutic areas.

He holds a PhD in Molecular Biology from University of Munich and Max-Planck Institute for Biochemistry (Martinsried) and had a post-doctoral fellowship at the European Molecular Biology Laboratory (EMBL), Heidelberg.